Edition:
India

Aduro Biotech Inc (ADRO.OQ)

ADRO.OQ on NASDAQ Stock Exchange Global Select Market

8.05USD
12:14am IST
Change (% chg)

$-0.05 (-0.62%)
Prev Close
$8.10
Open
$8.10
Day's High
$8.20
Day's Low
$8.00
Volume
120,758
Avg. Vol
112,157
52-wk High
$14.00
52-wk Low
$6.25

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.37 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.71 1.71 1.83 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 7 4.22 6.05 3.70 3.78
Quarter Ending Mar-18 4 4.49 6.70 3.70 3.70
Year Ending Dec-17 7 17.69 19.50 17.19 36.10
Year Ending Dec-18 6 38.21 74.82 15.02 59.31
Earnings (per share)
Quarter Ending Dec-17 7 -0.37 -0.30 -0.46 --
Quarter Ending Mar-18 5 -0.37 -0.36 -0.40 --
Year Ending Dec-17 7 -1.31 -1.22 -1.48 -1.52
Year Ending Dec-18 7 -1.42 -0.78 -1.66 -1.71

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 6.13 3.79 2.34 38.14
Quarter Ending Jun-17 11.19 5.92 5.28 47.14
Quarter Ending Mar-17 4.53 3.77 0.76 16.77
Quarter Ending Dec-16 3.85 3.88 0.03 0.77
Quarter Ending Sep-16 4.04 3.79 0.25 6.14

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4.22 4.67 4.67 6.09 3.78
Quarter Ending Mar-18 4.49 4.73 4.73 3.75 3.70
Year Ending Dec-17 17.69 18.12 18.12 22.30 36.10
Year Ending Dec-18 38.21 38.20 38.20 44.11 59.31

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 1 2 1 2
Quarter Ending Mar-18 1 0 1 0
Year Ending Dec-17 0 2 0 2
Year Ending Dec-18 1 0 1 0
Earnings